Yonehiro Grant — SEC Form 4 filings
SEC reporting owner CIK 1428666. 7 Form 4 filings on record with FilingPulse; latest filed 2026-09-21.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-03-06 to 2026-09-21. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 3 legs across 1 filing — 13,176 shares, $43,807 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 29.
- Largest priced transaction: sale of 6,850 shares @ $3.24 ($22,169) in Bolt Biotherapeutics, Inc., filed 2026-09-21.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | Chief Operating Officer | 7 | — | 3 legs · 13,176 sh · $43,807 | 29 |
Form 4 filings — Yonehiro Grant
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-21 | 4 | Bolt Biotherapeutics, Inc. (BOLT) | Sale (S): 1,417 @ $3.77 · Sale (S): 4,909 @ $3.32 · Sale (S): 6,850 @ $3.24 | EDGAR |
| 2026-02-04 | 4 | Bolt Biotherapeutics, Inc. (BOLT) | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2025-12-16 | 4 | Bolt Biotherapeutics, Inc. (BOLT) | Grant/award (A): 3,214 (derivative) · Disposition to issuer (D): 3,214 (derivative) · Grant/award (A): 660 (derivative) · Disposition to issuer (D): 660 (derivative) · Grant/award (A): 822 (derivative) · Disposition to issuer (D): 822 (derivative) · +18 more | EDGAR |
| 2025-10-24 | 4 | Bolt Biotherapeutics, Inc. (BOLT) | Grant/award (A): 30,000 @ $0 | EDGAR |
| 2025-05-05 | 4 | Bolt Biotherapeutics, Inc. (BOLT) | Grant/award (A): 350,000 (derivative) @ $0 | EDGAR |
| 2024-07-24 | 4 | Bolt Biotherapeutics, Inc. (BOLT) | Grant/award (A): 155,000 (derivative) @ $0 | EDGAR |
| 2024-03-06 | 4 | Bolt Biotherapeutics, Inc. (BOLT) | Grant/award (A): 235,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-02 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1428666 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →